When peripheral neuropathy occurs due to chemotherapy treatment, it is referred to as
chemotherapy-induced peripheral neuropathy (CIPN). Typically, symptoms are sensory …

Opinion statement Chemotherapy-induced peripheral neuropathy (CIPN) is a common
toxicity associated with treatment with platinum-based agents, taxanes, vinca alkaloids, and …

Oxidative stress, resulting from an imbalance between the formation of damaging free
radicals and availability of protective antioxidants, can contribute to peripheral neuropathic …

Chemotherapy-induced peripheral neuropathy (CIPN) develops as a challenging nerve-
damaging adverse effect of anticancer drugs used in chemotherapy. The disorder may …

To develop safer and potent analgesics, we designed, synthesized, and evaluated a new
series of benzylaminofentanyl derivates as bifunctional μ opioid receptor (MOR) and σ 1 …

Neuropathic pain is often closely associated with nerve injury or inflammation, and the role
of traditional nonsteroidal anti-inflammatory drugs as adjuvants for treating chemotherapy …

Chemotherapy-induced cachexia has been a significant challenge to the successful
treatment of cancer patients. Chemotherapy leads to loss of muscle, loss of appetite, and …

Ultrasound imaging texture analyses may provide information on tissue homogeneity
changes in metastatic breast cancer (MBC) through second-order analyzes based on the …

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of
anticancer treatment based on neurotoxic agents, which may affect function and health …

Objective The present study was designed to investigate the possible synergistic effects of
melatonin with zinc in the prevention and treatment of oxaliplatin-induced neurotoxicity in …